RUA.NZ NZE
Rua Bioscience Limited
1W: -3.6%
1M: -22.9%
3M: -6.9%
YTD: -15.6%
1Y: -53.5%
3Y: -74.3%
5Y: -92.4%
NZ$0.03 ($0.02)
+0.00 (+3.70%)
Weekly Expected Move ±11.1%
NZ$0
NZ$0
NZ$0
NZ$0
NZ$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$3M
+35.9% ▲
5Y CAGR: +48.3%
Gross Profit
-$1M
-236.6% ▼
Operating Income
-$3M
-2.1% ▼
Net Income
-$3M
+2.8% ▲
EPS (Diluted)
$-0.01
+50.0% ▲
EBITDA
-$3M
-1.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $24K | $358K | $86K | $2M | $3M |
| YoY Growth | -93.3% | +1376.4% | -76.0% | +2113.2% | +35.9% |
| Cost of Revenue | $129K | $340K | $204K | $977K | $4M |
| Gross Profit | -$5M | $18K | -$118K | $923K | -$1M |
| Gross Margin | -21537.0% | 5.1% | -137.8% | 48.6% | -48.8% |
| R&D Expenses | $3M | $2M | $1M | $945K | $848K |
| SG&A Expenses | $1M | $8M | $0 | $0 | $0 |
| Operating Expenses | $8M | $6M | $5M | $4M | $2M |
| Operating Income | -$8M | -$12M | -$5M | -$3M | -$3M |
| Operating Margin | -33857.0% | -3436.6% | -6115.1% | -173.6% | -130.4% |
| Interest Expense | $41K | $19K | $17K | $160K | $317K |
| Income Before Tax | -$7M | -$6M | -$14M | -$3M | -$3M |
| Tax Expense | $1M | $774 | $0 | $0 | -$124K |
| Net Income | -$9M | -$6M | -$14M | -$3M | -$3M |
| Net Margin | -35647.9% | -1666.1% | -15982.3% | -181.9% | -130.1% |
| EPS (Diluted) | $-0.06 | $-0.04 | $-0.09 | $-0.02 | $-0.01 |
| EBITDA | -$7M | -$5M | -$13M | -$3M | -$3M |
| Shares Outstanding | 150M | 154M | 158M | 173M | 336M |